Consensus document of the Spanish Society of Rheumatology on the use of opioids in the treatment of rheumatic pain;Documento de consenso de la Sociedad Española de Reumatología para el uso de opioides en el tratamiento del dolor reumático

Reumatologia Clinica

Volumn 2, Issue SPEC. ISS. 1, 2006, Pages 50-54

  Tornero Molina, J ^a   Vidal Fuentes, J ^a   Alonso Ruiz, A ^b   Acebes Cachafeiro, C ^c   Arboleya Rodriguez L ^d   Calvo Alen, J ^e   Francisco Hernandez F M ^f   Mayordomo Gonzalez L ^g   Ponce Vargas, A ^h   Pichot Pla C ⁱ   Revenga Martinez M ^j   Rodriguez de la Serna A ^k  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c Clinica Nuestra senora de America   (Spain)

^d HOSPITAL SAN AGUSTÍN   (Spain)

^e HOSPITAL SIERRALLANA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^g HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ Clinica Del Dolor De Barcelona   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ARTICLE; CHRONIC PAIN; CONSENSUS; DISEASE CONTROL; DRUG USE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MUSCULOSKELETAL DISEASE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SPAIN; TREATMENT PLANNING;

EID: 33645728786     PISSN: 1699258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Badley EM. The provision of reumatological services. En: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby UK; 1995.
2. Carmona L, Ballina J, Gabriel R. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60:1040-5.
3. Bellamy N, Bradley LA. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1996;39:357-62.
4. Nurmikko TJ, Nash TP, Wiles JR. Control of chronic pain. BMJ. 1998; 317:1438-41.
5. Conno F, Ripamonti C, Brunelli C. Opioid purchases and expenditure in nine western European countries: "Are we killing off morphine?". Palliative Medicine. 2005;19:179-84.
6. Woolf AD, Zeidler H, Haglund U, Carr AJ, Chaussade S, Cucinotta D, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis. 2004;63;342-7.
7. Kalso E, Allan L, Dellemijn P, Faura CC, Ilias WK, Jensen f, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003;7:381-6.
8. American Academy of Pain Medicine. Long-term controlled substances therapy for chronic pain. Sample agreement, 2001. Disponible en: http://www.painmed.org/productpub/statements/sample.html
9. Recommendations for the appropriateuse of opioids for persistent noncancer pain. The England Pain Society; 2004.
10. Jovey RD, Ennis J, Gardner-Nix J, Goldman B, Hays H, Lynch M, et al. Canadian Pain Society. Use of opioid analgesics for the treatment of chronic noncancer pain -a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag. 2003;8 Suppl A:A3-28.
11. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. En: Turk DC, Melzack R, editors. New York: Guilford Press; 2001. p. 15-34.
12. Ferraz MB, Quaresma MR, Aquino LRL, Atra E, Tugwell A, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1990;17:1022-4.
13. Turk DC, Okifuji A. Assessment of patients reporting of pain: an integnared perspective. Lancet. 1999;353:1784-8.
14. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355-65.
15. Guy W. ECDEU assessment manual for psicopharmacology (DHEW Publications No. ADM 76-338). Washington: US Government Printing Office; 1976.
16. Shen H, Aeschlimann A, Reisch N, Gay RE, Simmen BF, Michel BA, et al. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 2005;52:1402-10.
17. Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2004;26:1774-82.
18. Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002;23:278-91.
19. Griessinger N, Sittl R, Jost R, Schaefer M, Likar R. The role of opioid analgesics in rheumatoid disease in the elderly population. Drugs Aging. 2003;20:571-83.
20. Allan L, Hays H, Jensen NH, De Waroux BL, Bolt M, Donald R, et al. Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:1154-8.
21. Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther. 2003;25:150-68.
22. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N, Protocol TRP-CAN-1 Study Group. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004;31:2454-63.
23. Hale ME, Fleischmann R, Salzman R. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain. 1999;15:179-83.
24. Milligan K, Lanteri-Minet M, Borchert K. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain. 2001;2:197-204.
25. Mystakidou K, Parpa E, Tsilika E. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain. 2003;4:298-306.
26. Sorge J, Stadler T. Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain. Clin Drug Invest. 1997; 14:157-64.
27. Rosenthal NR, Silverfield JC, Wu SC, Jordan D, Kamin M. Tramadol/ acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriatr Soc. 2004;52:374-80.
28. Sorge J, Stadler T. Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain. Clin Drug Invest. 1997;14: 157-64.
29. Roth SH, Fleischmann RM, Burch FX. Around-the-clock, controlled-release oxycodone therapy for osteoarthrids-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853-60.
30. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203-17.
31. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Eng J Med. 2003;349:1943-53.
32. McQuay H. Opioids in pain management. Lancet. 1999;353:2229-32.
33. The use of opioids for the treatment of chronic pain: a consensus statement from American Academy of Pain Medicine and American Pain Society. Disponible en: http://www.ampainsoc.org/advocacy/opioids.htm